Glucose Sequence Similarity Modeling for Intervention Inference

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional continuous glucose monitoring (CGM) systems fail to utilize the sequential properties of glucose value data, limiting the inference of information between sequences with the same aggregate metrics, such as averages, which prevents effective determination of interventions that can maintain healthy blood glucose levels.

Innovation Solution

A similarity model is employed to compute similarity scores between sequences of glucose values by comparing probabilities given context data, identifying a particular sequence with a maximum similarity score, and generating an indication of associated externalities for user interfaces.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of information

If aggregate data metrics (e.g., average TIR) are used to analyze glucose data, then clinically useful information is provided, but the sequential property of the data is lost and cannot be utilized

Engineering Contradiction:
Improvesequential informationVSAvoiddata analysis complexity
Core Design Contradiction:
Loss of informationVSDevice complexity

Solution Approach 1:

The patent segments the glucose data into discrete time points and compares sequences of glucose values at different times. By breaking down the continuous glucose data into discrete temporal segments and comparing them, the system preserves sequential information while maintaining computational manageability through structured comparison frameworks.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces a temporal dimension to the analysis by comparing glucose sequences across different time points rather than using only aggregate metrics. This dimensional approach to time allows the system to capture sequential patterns and relationships between glucose values at different times, transforming the data from static aggregates to dynamic temporal patterns.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Loss of information

If each glucose value is treated as an independent observation, then simple aggregate metrics can be calculated, but information about the sequential property of CGM data is not captured

Engineering Contradiction:
Improvetemporal relationship informationVSAvoidglucose level measurement accuracy
Core Design Contradiction:
Loss of informationVSMeasurement precision

Solution Approach 1:

The patent performs preliminary organization of glucose data into sequences at discrete time points before analysis. By pre-structuring the data into temporal sequences and preparing comparison frameworks in advance, the system enables precise capture of temporal relationships while maintaining measurement accuracy through systematic comparison of pre-organized data structures.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS12502103B2Systems for determining similarity of sequences of glucose values
Publication Date: 2025.12.23 DEXCOM INC
  • US12502103B2 patent drawing
  • US12502103B2 patent drawing
  • US12502103B2 patent drawing

AI summary

In implementations of systems for determining a similarity of sequences of glucose values, a computing device implements a similarity system to receive input data describing a sequence of user glucose values measured by a continuous glucose monitoring (CGM) system. The similarity system computes similarity scores for a plurality of sequences of glucose values by comparing each glucose values included in the sequence of user glucose values with ever glucose value included in each sequence of the plurality of sequences. A particular sequence of glucose values that is associated with a highest similarity score is identified. The similarity system determines an externality associated with the particular sequence. The similarity system generates an indication of the externality for display in a user interface.